Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia

Docetaxel is a major anticancer drug that can induce hypersensitivity reactions leading to deleterious treatment interruptions. Blood hypereosinophilia could be a biological sign, potentially lethal, of delayed visceral hypersensitivity reactions. We hypothesized this biological event is probably un...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamdan, Diaddin, Leboeuf, Christophe, Le Foll, Christine, Bousquet, Guilhem, Janin, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537007/
https://www.ncbi.nlm.nih.gov/pubmed/30854809
http://dx.doi.org/10.1002/cam4.2062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537007/
https://www.ncbi.nlm.nih.gov/pubmed/30854809
http://dx.doi.org/10.1002/cam4.2062

Ejemplares similares